Warren Buffett discussed rational business valuation while Amgen's TSR exceeded its share price return.
1 report, 1 independent
Updated Jul 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Warren Buffett discussed rational business valuation while Amgen's TSR exceeded its share price return.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Warren Buffett
American investor, entrepreneur and businessman
-
TSR
former company, publisher of Dungeons & Dragons
Nothing else this week.
Related events
- Buffett's essay discusses how share prices don't reflect business value, specifically mentioning Gentherm Incorporated.
- Warren Buffett's investment strategy is contrasted with General Motors' current valuation.
- Warren Buffett published an essay discussing the principles of share price valuation.
- Warren Buffett advised against high costs related to Berkshire Hathaway.
- Berkshire Hathaway discussed the importance of long-term value strategy, patience, and the power of compounding, featuring Warren Buffett and Charlie Munger.
Coverage
Newest first; wire copies grouped- Simply Wall St.Amgen's (NASDAQ:AMGN) three-year earnings growth trails the 10% YoY shareholder returns Buying a low-cost index fund will get you the average market return. But across the board there are plenty of s